Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report)'s share price traded up 8.9% during mid-day trading on Tuesday . The stock traded as high as $33.70 and last traded at $32.19. 18,141,457 shares traded hands during trading, a decline of 18% from the average session volume of 22,197,922 shares. The stock had previously closed at $29.55.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on HIMS shares. Bank of America increased their target price on Hims & Hers Health from $21.00 to $22.00 and gave the stock an "underperform" rating in a research report on Tuesday, March 18th. Truist Financial lifted their price objective on Hims & Hers Health from $24.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. BTIG Research initiated coverage on Hims & Hers Health in a report on Tuesday, January 7th. They set a "buy" rating and a $35.00 target price for the company. Canaccord Genuity Group increased their target price on Hims & Hers Health from $38.00 to $68.00 and gave the stock a "buy" rating in a research note on Wednesday, February 19th. Finally, Leerink Partners boosted their target price on shares of Hims & Hers Health from $24.00 to $40.00 and gave the company a "market perform" rating in a research note on Tuesday, February 25th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $37.31.
Check Out Our Latest Research Report on HIMS
Hims & Hers Health Stock Down 7.4 %
The stock has a market cap of $5.76 billion, a PE ratio of 58.93 and a beta of 1.65. The stock has a fifty day moving average of $39.82 and a 200-day moving average of $29.94.
Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. The company had revenue of $481.14 million during the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. Equities research analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.
Insider Activity
In other news, CFO Oluyemi Okupe sold 11,581 shares of the company's stock in a transaction on Monday, January 13th. The shares were sold at an average price of $24.44, for a total value of $283,039.64. Following the transaction, the chief financial officer now directly owns 118,077 shares of the company's stock, valued at approximately $2,885,801.88. This represents a 8.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Soleil Boughton sold 4,152 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $60.69, for a total value of $251,984.88. Following the transaction, the insider now owns 157,345 shares in the company, valued at approximately $9,549,268.05. This trade represents a 2.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,078,738 shares of company stock worth $38,386,521. 17.71% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. Main Management ETF Advisors LLC acquired a new stake in shares of Hims & Hers Health in the third quarter valued at $672,000. Means Investment CO. Inc. increased its holdings in Hims & Hers Health by 23.5% during the 4th quarter. Means Investment CO. Inc. now owns 50,040 shares of the company's stock worth $1,210,000 after purchasing an additional 9,508 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Hims & Hers Health by 102.0% in the third quarter. Principal Financial Group Inc. now owns 290,414 shares of the company's stock valued at $5,349,000 after purchasing an additional 146,621 shares during the last quarter. State of Alaska Department of Revenue bought a new stake in Hims & Hers Health during the fourth quarter worth about $2,628,000. Finally, Pacer Advisors Inc. acquired a new stake in Hims & Hers Health in the fourth quarter valued at $374,000. Institutional investors and hedge funds own 63.52% of the company's stock.
Hims & Hers Health Company Profile
(
Get Free Report)
Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Featured Articles
Before you consider Hims & Hers Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims & Hers Health wasn't on the list.
While Hims & Hers Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
